In this episode of the “CURE Talks Cancer” podcast we spoke with two experts on the treatment landscape of metastatic urothelial carcinoma and what patients have to look forward to.
BY Kristie L. Kahl
The treatment paradigm for metastatic urothelial carcinoma has shifted significantly over the last decade with immunotherapy and precision medicine.
In this episode of the “CURE
Talks Cancer” podcast, we spoke with Dr. Elizabeth Plimack, chief of the Division of Genitourinary Medical Oncology at Fox Chase Cancer Center, Temple Health, and Dr. Sumanta (Monty) Pal, from City of Hope Comprehensive Cancer Center, about metastatic urothelial.
The experts discussed the treatment landscape for this disease, how patients can learn more about their options and what they have to look forward to on the horizon.